Clinical Trial Update: Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating transarterial chemoembolisation (TACE) plus axitinib in hepatocellular carcinoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Axitinib (Inlyta) (Axitinib)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED